Trial Profile
The Tolerability and Safety of Low Dose Primaquine for Transmission Blocking in Symptomatic Falciparum Infected Cambodians
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Primaquine
- Indications Falciparum malaria
- Focus Adverse reactions
- 16 Mar 2020 Results published in the Antimicrobial Agents and Chemotherapy
- 22 Aug 2016 Status changed from recruiting to completed.
- 31 Mar 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.